CellaVision AB (CEVI) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.058x

Based on the latest financial reports, CellaVision AB (CEVI) has a cash flow conversion efficiency ratio of 0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr51.43 Million ≈ $5.53 Million USD) by net assets (Skr887.58 Million ≈ $95.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CellaVision AB stock valuation for the company's overall valuation and market capitalisation.

CellaVision AB - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how CellaVision AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CellaVision AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CellaVision AB ranked by their cash flow conversion efficiency. Explore how high is CellaVision AB's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jiangling Motors Corp Ltd SHE:200550	0.212x
Alexander Marine Co Ltd TW:8478	0.024x
African Gold Ltd AU:A1G	-0.063x
Hey-Song Corp TW:1234	-0.001x
Deep Fission, Inc. Common Stock NASDAQ:FISN	-0.288x
Chung Hwa Chemical Industrial Works Ltd TW:1727	-0.018x
Sichuan Dawn Precision Technology Co Ltd SHE:300780	0.037x
Dongwon System KO:014820	0.072x

Annual Cash Flow Conversion Efficiency for CellaVision AB (2006–2025)

The table below shows the annual cash flow conversion efficiency of CellaVision AB from 2006 to 2025. View CellaVision AB (CEVI) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr887.58 Million ≈ $95.52 Million	Skr200.53 Million ≈ $21.58 Million	0.226x	-7.13%
2024-12-31	Skr815.73 Million ≈ $87.79 Million	Skr198.44 Million ≈ $21.36 Million	0.243x	-11.28%
2023-12-31	Skr716.39 Million ≈ $77.09 Million	Skr196.44 Million ≈ $21.14 Million	0.274x	+28.15%
2022-12-31	Skr641.63 Million ≈ $69.05 Million	Skr137.28 Million ≈ $14.77 Million	0.214x	-27.22%
2021-12-31	Skr543.28 Million ≈ $58.47 Million	Skr159.72 Million ≈ $17.19 Million	0.294x	+77.58%
2020-12-31	Skr429.62 Million ≈ $46.23 Million	Skr71.12 Million ≈ $7.65 Million	0.166x	-54.22%
2019-12-31	Skr348.37 Million ≈ $37.49 Million	Skr125.99 Million ≈ $13.56 Million	0.362x	+41.78%
2018-12-31	Skr290.38 Million ≈ $31.25 Million	Skr74.07 Million ≈ $7.97 Million	0.255x	-30.10%
2017-12-31	Skr240.85 Million ≈ $25.92 Million	Skr87.90 Million ≈ $9.46 Million	0.365x	-1.73%
2016-12-31	Skr206.18 Million ≈ $22.19 Million	Skr76.57 Million ≈ $8.24 Million	0.371x	-22.55%
2015-12-31	Skr183.52 Million ≈ $19.75 Million	Skr88.00 Million ≈ $9.47 Million	0.480x	+82.35%
2014-12-31	Skr151.30 Million ≈ $16.28 Million	Skr39.78 Million ≈ $4.28 Million	0.263x	+27.77%
2013-12-31	Skr132.52 Million ≈ $14.26 Million	Skr27.27 Million ≈ $2.93 Million	0.206x	+123.68%
2012-12-31	Skr124.91 Million ≈ $13.44 Million	Skr11.49 Million ≈ $1.24 Million	0.092x	-63.77%
2011-12-31	Skr126.07 Million ≈ $13.57 Million	Skr32.02 Million ≈ $3.45 Million	0.254x	+151.39%
2010-12-31	Skr113.42 Million ≈ $12.21 Million	Skr11.46 Million ≈ $1.23 Million	0.101x	-63.28%
2009-12-31	Skr74.80 Million ≈ $8.05 Million	Skr20.58 Million ≈ $2.21 Million	0.275x	+896.24%
2008-12-31	Skr45.98 Million ≈ $4.95 Million	Skr1.27 Million ≈ $136.67K	0.028x	-91.68%
2007-12-31	Skr20.07 Million ≈ $2.16 Million	Skr6.67 Million ≈ $717.37K	0.332x	+519.92%
2006-12-31	Skr17.73 Million ≈ $1.91 Million	Skr950.00K ≈ $102.24K	0.054x	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$418.90 Million

Skr3.89 Billion SEK

Market Cap Rank

#13275 Global

#212 in Sweden

Share Price

Skr163.20

Change (1 day)

-1.09%

52-Week Range

Skr118.40 - Skr188.40

All Time High

Skr478.48